SCHEMBL4726321

SCHEMBL4726321

CN1C2C[N]CC1C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL193461 0.81
SCHEMBL7944148 0.79
SCHEMBL9749368 0.77 MAPK1 (0.46)
SCHEMBL1922912 0.75
SCHEMBL3438658 0.69
SCHEMBL17856436 0.65 LMNA (0.35)
SCHEMBL23315663 0.65
SCHEMBL3438642 0.65
SCHEMBL18069713 0.65
SCHEMBL22630775 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019063708-A1 SUBSTITUTED 3-PHENYLQUINAZOLIN-4(3H)-ONES AND USES THEREOF BAYER AKTIENGESELLSCHAFT (DE) 2019-04-04 WO claimed
WO-2019063704-A1 SUBSTITUTED 3-PHENYLQUINAZOLIN-4(3H)-ONES AND USES THEREOF BAYER AKTIENGESELLSCHAFT (DE) 2019-04-04 WO claimed
WO-2008002575-A1 MELANIN CONCENTRATING HORMONE ANTAGONISTS THE PROCTER & GAMBLE COMPANY (US) 2008-01-03 WO claimed
US-20070299062-A1 Melanin concentrating hormone antagonists THE PROCTER & GAMBLE COMPANY (US) 2007-12-27 US claimed
WO-2019063704-A1 SUBSTITUTED 3-PHENYLQUINAZOLIN-4(3H)-ONES AND USES THEREOF BAYER AKTIENGESELLSCHAFT (DE) 2019-04-04 WO disclosed
WO-2019063708-A1 SUBSTITUTED 3-PHENYLQUINAZOLIN-4(3H)-ONES AND USES THEREOF BAYER AKTIENGESELLSCHAFT (DE) 2019-04-04 WO disclosed
WO-2008002575-A1 MELANIN CONCENTRATING HORMONE ANTAGONISTS THE PROCTER & GAMBLE COMPANY (US) 2008-01-03 WO disclosed
US-20070299062-A1 Melanin concentrating hormone antagonists THE PROCTER & GAMBLE COMPANY (US) 2007-12-27 US disclosed